Tango Therapeutics, Inc.

NASDAQ:TNGX

1.86 (USD) • At close March 13, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 4.11711.60719.8756.4715.43110.73214.5985.7666.4116.925.7715.7585.7166.78718.1536.3869.142-11.2615.0644.711
Kosten van de omzet 000.6320.6250.6170.6131.5081.4581.4521.220.6860.6721.63421.92319.0791515.06312.97711.12910.822
Brutowinst 4.11711.60719.2435.8464.81410.11913.094.3084.9595.75.0855.088-15.918-15.136-0.926-8.614-5.921-24.238-6.065-6.111
Brutowinstmarge 110.9680.9030.8860.9430.8970.7470.7740.8240.8810.884-2.785-2.23-0.051-1.349-0.6482.152-1.198-1.297
Onderzoek- en ontwikkelingskosten 33.93733.26338.65438.06531.33927.14928.67128.03929.09128.74423.74124.3321.63421.92319.0791515.06312.97711.12910.822
Algemene en administratieve kosten 11.0911.22210.77310.6619.1059.2099.1748.0137.8878.0997.2326.8076.0664.4333.633.4673.0162.5182.3781.953
Verkoop- en marketingkosten 00-0.632-0.6250000000000000000
Verkoop-, algemene en administratieve kosten 11.0911.22210.14110.0369.1059.2099.1748.0137.8878.0997.2326.8076.0664.4333.633.4673.0162.5182.3781.953
Overige kosten 001.9952.1842.0611.5142.6012.2781.5580.5230.05-0.0470.115-0.05-0.062-0.0550.0020.00400
Bedrijfskosten 45.02744.48548.79548.10140.44436.35837.84536.05236.97836.84330.97331.13727.726.35622.70918.46718.07915.4952.3541.863
Bedrijfsresultaat -40.91-32.878-29.552-42.255-35.013-25.626-23.247-30.286-30.567-29.923-25.202-24.99-21.984-19.569-4.556-12.081-8.937-26.756-8.443-8.064
Bedrijfsresultaat ratio -9.937-2.833-1.487-6.53-6.447-2.388-1.592-5.253-4.768-4.324-4.367-4.34-3.846-2.883-0.251-1.892-0.9782.376-1.667-1.712
Totaal overige inkomsten en kosten netto 3.2893.7654.0664.3814.2973.3862.6012.2781.5580.8730.3470.1710.1150.0410.0420.0490.073-0.0460.0510.15
Inkomen voor belasting -37.621-29.113-25.486-37.874-30.716-22.24-20.646-28.008-29.009-29.05-24.855-25.208-21.869-19.528-4.514-12.032-8.864-26.802-8.392-7.914
Inkomen voor belasting ratio -9.138-2.508-1.282-5.853-5.656-2.072-1.414-4.857-4.525-4.198-4.307-4.378-3.826-2.877-0.249-1.884-0.972.38-1.657-1.68
Belastingkosten 0.0490.0540.0650.040.0470.0230.064-2.2780.051-0.8730.003-0.1710.1770.062-0.0210.07400.0500
Nettowinst -37.67-29.167-25.551-37.914-30.763-22.263-20.71-25.73-29.06-28.177-24.858-25.037-22.046-19.59-4.493-12.106-8.864-26.802-8.392-7.914
Nettowinstmarge -9.15-2.513-1.286-5.859-5.664-2.074-1.419-4.462-4.533-4.072-4.307-4.348-3.857-2.886-0.248-1.896-0.972.38-1.657-1.68
WPA (Winst Per Aandeel) -0.34-0.27-0.24-0.35-0.32-0.23-0.23-0.29-0.33-0.32-0.28-0.29-0.25-0.28-0.051-0.14-0.53-0.31-0.75-0.74
Verwaterde WPA -0.34-0.27-0.24-0.35-0.32-0.23-0.23-0.29-0.33-0.32-0.28-0.29-0.25-0.28-0.051-0.14-0.42-0.31-0.75-0.74
EBITDA -40.29-32.256-28.92-41.63-34.396-25.013-22.643-29.705-29.997-29.506-24.89-25.07-21.728-19.344-4.344-11.877-8.746-26.57-8.266-7.9
EBITDA ratio -9.786-2.779-1.455-6.433-6.333-2.331-1.592-5.253-4.768-4.264-4.367-4.408-3.846-2.85-0.251-1.86-0.9572.376-1.632-1.677